CNS Pharmaceuticals, Inc.
CNSP
$6.12
-$0.42-6.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.38M | -4.30M | -3.18M | -5.61M | -2.53M |
| Total Depreciation and Amortization | 1.10K | 1.10K | 1.00K | 800.00 | 800.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.80K | 62.40K | 129.90K | 868.10K | 234.30K |
| Change in Net Operating Assets | -2.99M | 995.90K | -2.43M | -2.06M | 645.30K |
| Cash from Operations | -5.34M | -3.24M | -5.47M | -6.80M | -1.65M |
| Capital Expenditure | -- | -- | -4.20K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -4.20K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -88.90K | -86.90K | -31.20K | -92.10K | -89.90K |
| Issuance of Common Stock | 4.51M | 9.03M | 5.00M | 12.41M | 2.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 882.00K | -10.00K | -40.00K | -16.80K |
| Cash from Financing | 4.43M | 9.83M | 4.96M | 12.28M | 2.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -917.70K | 6.59M | -511.70K | 5.48M | 676.30K |